These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 2857420)

  • 1. Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours.
    Neal DE; Marsh C; Bennett MK; Abel PD; Hall RR; Sainsbury JR; Harris AL
    Lancet; 1985 Feb; 1(8425):366-8. PubMed ID: 2857420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
    Messing EM
    Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histochemical study of lectin binding in neoplastic and non-neoplastic urothelium.
    Neal DE; Charlton RG; Bennett MK
    Br J Urol; 1987 Nov; 60(5):399-404. PubMed ID: 3322471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
    Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
    Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor in the normal and neoplastic kidney and bladder.
    Lau JL; Fowler JE; Ghosh L
    J Urol; 1988 Jan; 139(1):170-5. PubMed ID: 3275797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the expression of epidermal growth factor, transforming growth factor alpha, and epidermal growth factor receptor on the prognosis of superficial bladder cancer.
    Türkeri LN; Erton ML; Cevik I; Akdaş A
    Urology; 1998 Apr; 51(4):645-9. PubMed ID: 9586623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nuclear form of the heparin-binding epidermal growth factor-like growth factor precursor is a feature of aggressive transitional cell carcinoma.
    Adam RM; Danciu T; McLellan DL; Borer JG; Lin J; Zurakowski D; Weinstein MH; Rajjayabun PH; Mellon JK; Freeman MR
    Cancer Res; 2003 Jan; 63(2):484-90. PubMed ID: 12543806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.
    Wright C; Mellon K; Johnston P; Lane DP; Harris AL; Horne CH; Neal DE
    Br J Cancer; 1991 Jun; 63(6):967-70. PubMed ID: 1712624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 and erbB-2 protein overexpression are associated with early invasion and metastasis in bladder cancer.
    Moch H; Sauter G; Moore D; Mihatsch MJ; Gudat F; Waldman F
    Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):329-34. PubMed ID: 7509541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of epidermal growth factor receptors in bladder tumours.
    Berger MS; Greenfield C; Gullick WJ; Haley J; Downward J; Neal DE; Harris AL; Waterfield MD
    Br J Cancer; 1987 Nov; 56(5):533-7. PubMed ID: 3426916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancer.
    Ravery V; Grignon D; Angulo J; Pontes E; Montie J; Crissman J; Chopin D
    Urol Res; 1997; 25(1):9-17. PubMed ID: 9079740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
    Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder carcinomas and normal urothelium universally express gp200-MR6, a molecule functionally associated with the interleukin 4 receptor (CD 124).
    Tungekar MF; Gatter KC; Ritter MA
    Br J Cancer; 1996 Feb; 73(4):429-32. PubMed ID: 8595155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferrin receptor expression by human bladder transitional cell carcinomas.
    Seymour GJ; Walsh MD; Lavin MF; Strutton G; Gardiner RA
    Urol Res; 1987; 15(6):341-4. PubMed ID: 3324443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of epidermal growth factor receptor (EGFr) expression in human malignancies: effects of exposure to EGF and its biological influence on established human tumour cell lines.
    Nouri AM; Thompson C; Cannell H; Symes M; Purkiss S; Amirghofran Z
    Int J Mol Med; 2000 Oct; 6(4):495-500. PubMed ID: 10998445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the type 1 tyrosine kinase growth factor receptors EGF receptor, c-erbB2 and c-erbB3 in bladder cancer.
    Rajkumar T; Stamp GW; Pandha HS; Waxman J; Gullick WJ
    J Pathol; 1996 Aug; 179(4):381-5. PubMed ID: 8869284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth.
    Gómez-Román JJ; Saenz P; Molina M; Cuevas González J; Escuredo K; Santa Cruz S; Junquera C; Simón L; Martínez A; Gutiérrez Baños JL; López-Brea M; Esparza C; Val-Bernal JF
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):459-65. PubMed ID: 15701828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
    Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
    J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the epidermal growth factor receptor family in normal and malignant urothelium.
    Røtterud R; Nesland JM; Berner A; Fosså SD
    BJU Int; 2005 Jun; 95(9):1344-50. PubMed ID: 15892828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of epidermal growth factor receptor and p53 protein in superficial cancer of the urinary bladder].
    Busto Castañón L; Sánchez Merino JM; Picallo Sánchez JA; Gelabert Mas A
    Arch Esp Urol; 2001; 54(1):13-21. PubMed ID: 11296668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.